Abu Dhabi: Mubadala Healthcare and Strata Manufacturing (Strata), Mubadala’s composite aero-structures manufacturing company, are collaborating to manufacture essential medical supplies and support the fight against COVID-19, utilizing additive manufacturing to produce intubation capsule, face shields and ear guards.
The cooperation is part of Mubadala’s #WeAreDedicated campaign aimed at fostering collaboration across diverse enterprises and sectors to protect the community, and to support the UAE government in its COVID-19 response and mitigation.
A joint team was established to identify the requirements and business needs of the health sector. The team includes representatives from Mubadala Healthcare – a unit that created partnerships with international medical institutions to address the region’s most pressing healthcare needs, and Strata – a leading aero-structures manufacturing company in the global aerospace supply chain.
The team developed an innovative intubation capsule to optimize care and safety for COVID-19 patients and health workers, along with preventing the spread of the virus in the community. In addition, the team is producing ear guards for health workers that alleviate pressure on the ears caused by prolonged use of masks.
Hasan Jasem Al Nowais, Senior Vice President at Mubadala Healthcare, said: “While face shields and ear guards will increase health workers’ safety and comfort, the patient intubation capsule is expected to be a game-changer in the treatment of COVID-19 in individuals with respiratory problems. We are dedicated to leveraging the Mubadala Healthcare network and our partnership with Strata to develop home-grown UAE innovations that can provide the highest standards of patient and caregiver care. This is in line with Mubadala Healthcare’s commitment to spearhead innovation and research for the healthcare sector.”
One of the biggest challenges for healthcare providers treating patients with respiratory problems is protecting caregivers from infection. The COVID-19 patient intubation capsule developed by Strata is a self-contained plastic box, which fits around a patient’s face and head to allow for proper ventilation, and provides caregivers with an additional layer of protection from infected patients. Negative pressure inside the box expels the air using a pump and filter.
The COVID-19 Patient Intubation Capsule is the latest solution developed between Mubadala Healthcare and Strata, and the companies will continue to look for opportunities to collaborate.
Ismail Ali Abdulla, CEO of Strata, said: “Building on the strong partnership with Mubadala Healthcare, Cleveland Clinic Abu Dhabi and Healthpoint, and in response to the needs of Mubadala Healthcare facilities, we have managed to rapidly prototype and trial COVID-19 coronavirus healthcare innovations. Our COVID-19 medical supplies highlight the valuable role of manufacturing companies during those unprecedented times. The Mini-Capsule and Mini-Capsule Plus is a lifesaving initiative that tackles major health issues caused by COVID-19 through the utilization of Strata’s 3D printing capabilities.”
“As we continue to deliver high-quality aircraft parts to our customers, our aim is to utilize our industrial and technological capabilities to support the UAE government’s self-sufficiency in the healthcare supply chain, and we are aiming to share these COVID-19 innovations on a global scale.”
Mubadala Healthcare has enlisted the help of its Cleveland Clinic Abu Dhabi and Healthpoint facilities to trial the COVID-19 patient facial casing prototype in non-live conditions. In addition, Cleveland Clinic Abu Dhabi’s infection control experts will provide medical opinions, supply chain support, and clinical engineering.
Dr Madhu Sasidhar, Chief Medical Officer at Cleveland Clinic Abu Dhabi, said: “COVID-19 patients and caregivers need the highest standards of care and protection. This COVID-19 patient intubation capsule ensures that our caregivers can remain safe from coronavirus infection. Our tests in non-live conditions will help to accelerate the delivery of a finalized intubation capsule product.”
Once Cleveland Clinic Abu Dhabi and Healthpoint experts, Mubadala Healthcare, and the Abu Dhabi government approve the facial casing, Strata will convert working prototypes into mass production. Strata has also donated more than 350,000 gloves and 1,000 mask clips to Mubadala Healthcare medical facilities as part of the collaboration between the two entities.
-Ends-
About Mubadala Investment Company
Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for its shareholder, the Government of Abu Dhabi.
Mubadala’s US $229 billion portfolio spans five continents with interests in multiple sectors including aerospace, ICT, semiconductors, metals and mining, renewable energy, oil and gas, petrochemicals, utilities, healthcare, real estate, pharmaceuticals and medical technology, agribusiness and a global portfolio of financial holdings across all asset classes. Mubadala has offices in Rio de Janeiro, Moscow, New York, San Francisco, and London.
Mubadala is a trusted partner, an engaged shareholder and a responsible global company that is committed to world-class standards of governance.
Media Contacts
Salma Chalak, Consultant, Wallis PR
Telephone: +071 58 982 9525
Email: salma.chalak@wallispr.com
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
